Acute Gout Treatment Guidelines
Introduction to Treatment Options
- The American College of Rheumatology recommends using NSAIDs at full anti-inflammatory doses, colchicine, or corticosteroids for acute gout treatment, with dose adjustments required for renal impairment 1, 2, 3
NSAIDs: Dosing and Frequency
- Indomethacin is FDA-approved at full anti-inflammatory doses for acute gout 1, 2, 3
- Sulindac is also FDA-approved for acute gout treatment 1, 2, 3
- Other NSAIDs at analgesic/anti-inflammatory doses may be equally effective 1, 2, 3
- The American College of Rheumatology emphasizes maintaining full-dose NSAID therapy throughout the attack rather than early dose reduction 1, 2, 3
Colchicine: Dosing and Frequency
- Colchicine should be dosed as 1.2 mg loading dose followed by 0.6 mg one hour later, but ONLY if treatment begins within 36 hours of symptom onset 1, 2, 3
- This low-dose regimen has comparable efficacy to high-dose regimens with significantly fewer adverse effects 1, 2, 3
- After the initial loading doses, continue with 0.6 mg once or twice daily starting 12 hours after the second dose until the attack resolves 1, 2, 3
Corticosteroids: Dosing and Frequency
- Prednisone should be dosed at 0.5 mg/kg per day (approximately 30-35 mg for average adults) for 5-10 days at full dose then stopped abruptly, OR given for 2-5 days at full dose followed by a 7-10 day taper 4, 5
- The American College of Rheumatology recommends the non-tapered approach for straightforward monoarticular cases without significant comorbidities 5
- For severe attacks, polyarticular involvement, or patients at higher risk for rebound flares, use the tapered approach 5
Treatment Selection Algorithm
- For patients with renal impairment (CrCl <30 mL/min), avoid NSAIDs and use corticosteroids as first-line 4, 5
- For patients with cardiovascular disease, heart failure, cirrhosis, peptic ulcer disease, or anticoagulation, prefer corticosteroids over NSAIDs 5
- For patients with uncontrolled diabetes, active infection, or recent GI bleeding, avoid corticosteroids 4
Prophylaxis During Urate-Lowering Therapy
- Provide prophylaxis with colchicine 0.6 mg once or twice daily for at least 6 months, or for 3 months after achieving target uric acid levels without tophi 6
- In patients with renal impairment history, use colchicine only after renal function normalizes with appropriate dose adjustment 4
- Low-dose prednisone (<10 mg/day) can be used as second-line prophylaxis if colchicine and NSAIDs are contraindicated 5